BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24396405)

  • 1. mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis.
    Zhang X; Xie J; Yu C; Yan L; Yang Z
    Exp Ther Med; 2014 Feb; 7(2):360-364. PubMed ID: 24396405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
    Cui Y; Wang W; Yao S; Qiu Z; Cong L
    J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of CK19, LUNX, and KS1/4 mRNA expression in the peripheral blood for diagnosis of micrometastases in patients with non-small cell lung cancer and their clinical implications.
    Yan L; Yao Y; Wang LH; Wang ML; Fu XH
    Genet Mol Res; 2015 Nov; 14(4):15090-5. PubMed ID: 26634471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Feasibility and its clinical significance of detection of LUNX mRNA expression in diagnosis of micrometastasis for non-small cell lung cancer].
    Zhang P; Liu Y; Chen J; Song S; Shang Z
    Zhongguo Fei Ai Za Zhi; 2006 Dec; 9(6):506-10. PubMed ID: 21182811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.
    Cheng M; Chen Y; Yu X; Tian Z; Wei H
    BMC Cancer; 2008 May; 8():156. PubMed ID: 18513434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma.
    Yu H; Huang X; Zhu Z; Hu Y; Ou W; Zhang L; Zhou N
    Chin J Cancer Res; 2014 Feb; 26(1):89-94. PubMed ID: 24653630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer.
    Iwao K; Watanabe T; Fujiwara Y; Takami K; Kodama K; Higashiyama M; Yokouchi H; Ozaki K; Monden M; Tanigami A
    Int J Cancer; 2001 Feb; 91(4):433-7. PubMed ID: 11251963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer and its relations to the micrometastasis in peripheral blood.
    Jin Y; Xiong X; Su Y; Hu J; Tao X
    J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):462-5. PubMed ID: 19662363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [LUNX mRNA in regional lymph nodes of non-small cell lung cancer patients by RT-PCR and its clinical significance].
    Tan S; Cheng Z; Ma Y; Tan S; Yin Z; Hu W; Yu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1236-41. PubMed ID: 21200090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
    Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Wu KL; Zhao S
    Lung Cancer; 2007 Apr; 56(1):105-14. PubMed ID: 17166620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
    Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
    Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of CK19 and CEA mRNA expression for the diagnosis of peripheral blood micrometastases in patients with non-small cell lung cancer].
    Zhu G; Liu D; Wang X; Chen J
    Zhongguo Fei Ai Za Zhi; 2004 Jun; 7(3):226-9. PubMed ID: 21232224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between the mRNA levels of carcinoembryonic antigen and cytokeratin 19 in peripheral blood with staging, treatment response and prognosis in patients with lung cancer].
    Wang JH; Zhang SC; Liu ZD; Chen XY; Li CY; Han Y; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):773-6. PubMed ID: 16324274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of CK19 mRNA and EGFR mRNA in the peripheral blood and its relationship with lymphatic metastasis in laryngeal carcinoma model].
    Wu W; Hu G; Kang N; Jiang J; Yang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 25(11):501-5. PubMed ID: 21845829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of mRNA expression of CK-19 and MUC1 gene for diagnosis of lymph node micrometastasis in NSCLC patients by reverse transcriptase-polymerase chain reaction].
    Niu Z; Zhou Q; Sun Z; Sun Z; Zhu W; Wang Y; Che G; Qin J; Che X
    Zhongguo Fei Ai Za Zhi; 2004 Jun; 7(3):209-13. PubMed ID: 21232220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma LUNX mRNA, a non-invasive specific biomarker for diagnosis and prognostic prediction of non-small cell lung cancer.
    Zhou HX; Yang MX; Wang Y; Cao WM; Lu KF; Zong LY; Wu RQ; Zhang P
    Am J Cancer Res; 2016; 6(2):452-8. PubMed ID: 27186415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.